Eli Lilly’s Alzheimer’s drug approved by FDA AxiosFDA approves second Alzheimer’s drug that can slow onset of disease The GuardianFDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease CNNApproval of Newest Alzheimer’s Drug Will Accelerate New Era of Treatment The Wall Street Journal